Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Compositions and methods of use of A2 adenosine receptor (AR) agonists for treating conditions modulated by A2A and A2B ARs including myocardial ischemia, reperfusion injury, cystic fibrosis, erectile dysfunction, inflammation, restenosis and septic shock More
An Endothelial lined Stent for Rapid Endothelialization and Preventing Restenosis More
A strategy for artificially inducing the internalization of surface receptors, thereby blocking the effects of the ligands associated with that receptor More
Device and Process for Economical, Semi-Continuous Biodegradable Microsphere Production More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 15 pages - $500
Jan 2006 - 1126 pages - $2,495
Aug 2008 - 120 pages - $1,040
May 2011 - 43 pages - $500
Nov 2010 - 40 pages - $500
Dec 2010 - 25 pages - $500
May 2007 - 183 pages - $2,875
Mar 2011 - 26 pages - $500
May 2011 - 150 pages - $3,995
Dec 2010 - 18 pages - $125
Your selection
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Angioplasty
- Anti-angiogenesis
- Cardioprotection
- Cardiovascular surgery
- Coronary artery angioplasty/bypass
- Percutaneous transluminal angioplasty
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us